# Koios Care

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/koios-care

- Industry: Healthcare IT
- Headquarters: Antwerp, Belgium
- Website: www.koios.care
- Total disclosed funding: $1.1M
- Latest round: Seed (Jun 6, 2025)
- Investors on record: 4

## About

Based in Antwerp, Belgium, and founded in 2022 by CEO Konstantinos Kyritsis, and CTO Dimitris Iakovakis, Koios Care BV is a health technology company that develops digital, daily activity biomarkers for the treatment of neurodegenerative diseases, specifically Parkinson’s Disease by leveraging sensing and AI (artificial intelligence) technologies. In June 2025, Koios Care raised EUR 1 million in seed funding led by new investor Evercurious VC, with participation from other new investors Astylab Ventures and imec.istart fund. Individual investors also participated in the round. The company provides digital daily activity biomarkers with a wide range of features, such as a quality of life index based on validated digital biomarkers to augment clinical care, early-stage and disease progression screening, detection and monitoring of Parkinson’s disease symptoms, early population triaging for clinical trials, medication effectiveness quantification, and passive monitoring of physical activity, sleep quality, social behavior, drug adherence and meal intake for personalized insights. The company will use the June 2025 funding for further research and development.

## Funding rounds

- Seed, Jun 6, 2025, $1.1M — Imec.xpand, Hellenic Business Angels Network, Astylab Ventures, Evercurious VC

## Investors

- Imec.xpand (https://capitalatlas.ai/funds/imec-xpand) — Seed
- Hellenic Business Angels Network (https://capitalatlas.ai/funds/hellenic-business-angels-network) — Seed
- Astylab Ventures — Seed
- Evercurious VC (https://capitalatlas.ai/funds/evercurious-vc) — Seed